Accueil   Diary - News   All news CleveXel Pharma to license two new oncology patents from SATT Sud Est

CleveXel Pharma to license two new oncology patents from SATT Sud Est

ClemexelCleveXel Pharma, a highly experienced pharmaceutical developer that conforms fully with global regulatory compliance, today announces that it has been granted a license by the SATT Sud Est, a technology transfer accelerator in South Eastern France (Societe d’Acceleration du Transfert de Technologies Sud Est), to exploit two patents.

 

Read the press release